| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.091 | 0.09 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.096 | 0.1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |